WebOct 7, 2024 · CytoDyn intends to file with the SEC a definitive proxy statement and associated proxy card in connection with the solicitation of proxies for the Company’s … WebJul 16, 2024 · The investigation by a law firm for current long term investors in OTC: CYDY stocks follows a lawsuit filed against CytoDyn Inc. over alleged securities laws …
10-Q: CYTODYN INC. - MarketWatch
WebJul 16, 2024 · The investigation by a law firm for current long term investors in OTC: CYDY stocks follows a lawsuit filed against CytoDyn Inc. over alleged securities laws violations. The investigation on ... WebApr 14, 2024 · Further, the complaint, filed in Washington federal court, alleges CytoDyn, in addition to “overstating the viability of Leronlimab as a COVID-19 treatment,” also engaged in a wrongful scheme with its lender, non-party Iliad Research and Trading L.P., and its principal whereby the entities operated as an unregistered securities dealer for ... starlight theatre kansas city 2023 schedule
SEC.gov SEC Charges Former CEO of Biotech Company …
WebFeb 22, 2024 · The statement reviewed the results of two clinical trials, CD10 and CD12, conducted by CytoDyn investigating leronlimab for the treatment of COVID-19. In part, the statement provided, “With the ... WebOct 7, 2024 · CytoDyn intends to file with the SEC a definitive proxy statement and associated proxy card in connection with the solicitation of proxies for the Company’s 2024 Annual Meeting. Details concerning the nominees of the Company’s Board of Directors for election at the 2024 Annual Meeting will be included in the proxy statement. Web11 rows · CytoDyn is a publicly traded late stage biotechnology company developing innovative treatments for multiple therapeutic indications based on Leronlimab, a novel … starlight theatre kansas city concerts